Tikehau Investment Management Trims Stock Position in Waters Corporation $WAT

Tikehau Investment Management reduced its stake in Waters Corporation (NYSE:WAT) by 4.6% during the 2nd quarter, HoldingsChannel reports. The firm owned 6,337 shares of the medical instruments supplier’s stock after selling 306 shares during the period. Waters accounts for 3.4% of Tikehau Investment Management’s portfolio, making the stock its 11th biggest position. Tikehau Investment Management’s holdings in Waters were worth $2,212,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Zions Bancorporation National Association UT purchased a new position in Waters in the 1st quarter valued at $28,000. IFP Advisors Inc boosted its holdings in shares of Waters by 118.9% in the first quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier’s stock valued at $30,000 after acquiring an additional 44 shares in the last quarter. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Waters in the first quarter valued at about $41,000. Creative Financial Designs Inc. ADV increased its stake in shares of Waters by 533.3% during the second quarter. Creative Financial Designs Inc. ADV now owns 190 shares of the medical instruments supplier’s stock worth $66,000 after acquiring an additional 160 shares during the period. Finally, Steph & Co. purchased a new position in Waters during the second quarter worth about $73,000. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the company. JPMorgan Chase & Co. lifted their price objective on Waters from $300.00 to $325.00 and gave the company a “neutral” rating in a report on Thursday, October 9th. Rothschild & Co Redburn started coverage on Waters in a research note on Wednesday, October 8th. They set a “buy” rating and a $390.00 target price for the company. Wells Fargo & Company lifted their price target on Waters from $315.00 to $385.00 and gave the company an “equal weight” rating in a research note on Wednesday. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Waters in a report on Wednesday, October 8th. Finally, UBS Group reissued a “neutral” rating on shares of Waters in a report on Tuesday, July 15th. Two equities research analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $381.57.

Waters Price Performance

Shares of NYSE:WAT opened at $371.97 on Friday. The firm has a market capitalization of $22.15 billion, a price-to-earnings ratio of 33.54, a price-to-earnings-growth ratio of 3.19 and a beta of 1.11. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.75 and a quick ratio of 1.22. The business’s 50 day simple moving average is $323.54 and its 200-day simple moving average is $326.08. Waters Corporation has a 12 month low of $275.05 and a 12 month high of $423.56.

Waters (NYSE:WAT) last issued its quarterly earnings data on Thursday, May 19th. The medical instruments supplier reported $2.29 earnings per share (EPS) for the quarter. The firm had revenue of $608.55 million during the quarter. Waters had a return on equity of 38.60% and a net margin of 21.71%. As a group, equities analysts forecast that Waters Corporation will post 12.86 earnings per share for the current fiscal year.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.